Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Thyroid Eye Disease (TED) Market Expected To Grow In Terms Of Size?

The market size for thyroid eye disease (ted) has been expanding significantly in the previous years. It is projected to increase from $2.15 billion in 2024 to $2.29 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth during the historic period include an increase in thyroid disorders, a greater emphasis on patient-focused care, a rise in demand for cosmetic procedures, elevated incidences of the disease, and more available treatment options for TED.

The market size of Thyroid Eye Disease (TED) is likely to witness significant expansion in the upcoming years. The growth is estimated to reach $2.94 billion in 2029, marking a Compound Annual Growth Rate (CAGR) of 6.4%. This anticipated increase during the projected period can be related to an increasing number of Graves’ disease cases, escalated funding in diverse sectors, a rise in healthcare spending, a greater reliance on thyroid hormone replacement therapy, and an increasing occurrence of thyroid disease. Key trends for the projected period include breakthroughs in technology, ramped up research and development activities, the creation of innovative drugs, advancements in therapeutic procedures, and the introduction of novel surgical techniques.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

What Market Forces Are Contributing To The Growth Of The Thyroid Eye Disease (TED) Market?

The increase in thyroid-related illnesses is anticipated to boost the expansion of the thyroid eye disease (TED) market. These illnesses, which impact the operation of the thyroid gland, cause hormonal imbalances and lead to conditions like hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The rise in thyroid ailments can be attributed to factors such as excessive intake of iodine, autoimmune diseases, genetic vulnerability, and better awareness leading to improved diagnostic procedures. Thyroid Eye Disease (TED) adds to the growing number of thyroid disorder cases, as it is a frequent and severe complication of Graves’ disease, therefore, increasing the overall load and recognition of thyroid-related illnesses. For example, the Canadian Cancer Society, a community-based non-profit organization in Canada, projected in May 2024 that there would be about 6,600 new cases of thyroid cancer, resulting in approximately 280 deaths. Hence, the surge in thyroid disorders is pushing the advancement of the thyroid eye disease (TED) market.

How Is The Thyroid Eye Disease (TED) Market Segmented Across Key Categories?

The thyroid eye disease (ted)market covered in this report is segmented –

1) By Treatment Type: Medical; Surgical; Combination Of Medical And Surgical

2) By Disease Severity: Mild; Moderate; Severe

3) By Drug Type: Biologics; Small Molecules; Others Drug Type

4) By Route Of Administration: Oral; Intravenous; Subcutaneous

5) By End User: Hospitals; Clinics; Other End Users

Subsegments:

1) By Medical: Corticosteroids; Teprotumumab; Antithyroid Medications; Other Medical Treatments

2) By Surgical: Orbital Decompression Surgery; Eyelid Surgery; Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression; Combination of Teprotumumab and Eyelid Surgery; Other Combined Approaches

What Key Trends Are Driving Growth In The Thyroid Eye Disease (TED) Market?

Major companies in the thyroid eye disease (TED) market are prioritizing innovative solutions like monoclonal antibody therapies to develop targeted treatments that reduce inflammation, improve proptosis, and enhance patient outcomes. Monoclonal antibody therapies involve lab-produced antibodies designed to mimic the immune system’s ability to target and neutralize specific abnormal cells or pathogens. For example, in September 2024, Amgen Inc., a US biotechnology firm, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved TEPEZZA (teprotumumab) for active thyroid eye disease (TED), a rare and potentially vision-threatening autoimmune disorder. TEPEZZA is the first and only FDA-approved treatment specifically for TED, offering targeted relief by reducing inflammation, swelling, and other severe symptoms. This approval provides a critical new option for patients in Japan suffering from TED, a progressive condition characterized by debilitating eye bulging, vision impairment, and eye pain.

Who Are The Major Stakeholders Operating In The Thyroid Eye Disease (TED) Market?

Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report

How Do Regional Dynamics Influence The Thyroid Eye Disease (TED) Market Performance?

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21300&type=smp

Browse Through More Reports Similar to the Global Thyroid Eye Disease (TED) Market 2025, By The Business Research Company

Thyroid Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Anti Thyroid Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Parathyroid Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model